Open AccessClinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
Author(s) -
Yeo Jin Choi,
Yong Won Choi,
Jung-Woo Chae,
Hwi-yeol Yun,
Sug Kyun Shin
Publication year - 2021
Publication title -
risk management and healthcare policy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.828
H-Index - 22
ISSN - 1179-1594
DOI - 10.2147/rmhp.s306760
Subject(s) - medicine , warfarin , anticoagulant , adverse effect , deep vein , thrombosis , cancer , venous thrombosis , intensive care medicine , surgery , atrial fibrillation
Cancer patients are at increased risk for venous thromboembolism (VTE) due to cancer-induced hypercoagulability. However, current guidelines do not routinely recommend prophylactic use of oral anticoagulants to prevent VTE in cancer patients.